Entrez ID
Entrez Gene ID - the GENE ID in NCBI Gene database.
|
9971
|
Gene name
Gene Name - the full gene name approved by the HGNC.
|
Nuclear receptor subfamily 1 group H member 4 |
Gene symbol
Gene Symbol - the official gene symbol approved by the HGNC.
|
NR1H4 |
Synonyms (NCBI Gene)
Gene synonyms aliases
|
BAR, FXR, HRR-1, HRR1, PFIC5, RIP14 |
Disease Acronyms (UniProt)
Disease acronyms from UniProt database
|
PFIC5 |
Chromosome
Chromosome number
|
12 |
Chromosome location
Chromosomal Location - indicates the cytogenetic location of the gene or region on the chromosome.
|
12q23.1 |
Summary
Summary of gene provided in NCBI Entrez Gene.
|
This gene encodes a ligand-activated transcription factor that shares structural features in common with nuclear hormone receptor family members. This protein functions as a receptor for bile acids, and when bound to bile acids, binds to DNA and regulates |
UniProt ID |
Q96RI1
|
Protein name |
Bile acid receptor (Farnesoid X-activated receptor) (Farnesol receptor HRR-1) (Nuclear receptor subfamily 1 group H member 4) (Retinoid X receptor-interacting protein 14) (RXR-interacting protein 14) |
Protein function |
Ligand-activated transcription factor. Receptor for bile acids (BAs) such as chenodeoxycholic acid (CDCA), lithocholic acid, deoxycholic acid (DCA) and allocholic acid (ACA). Plays a essential role in BA homeostasis through the regulation of gen |
PDB |
1OSH
,
3BEJ
,
3DCT
,
3DCU
,
3FLI
,
3FXV
,
3GD2
,
3HC5
,
3HC6
,
3L1B
,
3OKH
,
3OKI
,
3OLF
,
3OMK
,
3OMM
,
3OOF
,
3OOK
,
3P88
,
3P89
,
3RUT
,
3RUU
,
3RVF
,
4OIV
,
4QE8
,
4WVD
,
5IAW
,
5ICK
,
5Q0I
,
5Q0J
,
5Q0K
,
5Q0L
,
5Q0M
,
5Q0N
,
5Q0O
,
5Q0P
,
5Q0Q
,
5Q0R
,
5Q0S
,
5Q0T
,
5Q0U
,
5Q0V
,
5Q0W
,
5Q0X
,
5Q0Y
,
5Q0Z
,
5Q10
,
5Q11
,
5Q12
,
5Q13
,
5Q14
,
5Q15
|
Family and domains |
Pfam
Accession |
ID |
Position in sequence |
Description |
Type |
PF00105
|
zf-C4 |
135 → 204 |
Zinc finger, C4 type (two domains) |
Domain |
PF00104
|
Hormone_recep |
289 → 471 |
Ligand-binding domain of nuclear hormone receptor |
Domain |
|
Tissue specificity |
TISSUE SPECIFICITY: Liver and hepatocyte-related cells express mainly FXRalpha1-type isoforms with isoform 3 and isoform 4 in approximately equal proportions. In intestine and kidney mainly FXRalpha2-type isoforms are expressed with isoform 1 and isoform |
Sequence |
|
Sequence length |
486 |
Interactions |
View interactions
|
Causal |
Disease term |
Disease name |
dbSNP ID |
References |
Cholestasis |
Cholestasis |
rs121909103, rs751511532, rs376368459, rs762702807, rs1578490102, rs1578499691, rs1578504946, rs1317656688, rs199791850, rs1452792080, rs1578491039 |
23178280, 22461449 |
Cholestasis of pregnancy |
Cholestasis of pregnancy |
rs11568372, rs121918440, rs387906527, rs72552778, rs387906528, rs72552780, rs769910565, rs188824058, rs375315619, rs754287486, rs764513998, rs759202962, rs377160065, rs1562965036, rs764296800, rs1584665400, rs1584671714, rs1187517509, rs1584684209, rs533310204, rs571555115, rs1584754706, rs1584754766, rs1584763429, rs757693457, rs1574445178, rs1584742063, rs1584750660, rs752563752 View all (14 more) |
23142591 |
Intrahepatic cholestasis |
Progressive intrahepatic cholestasis (disorder), CHOLESTASIS, PROGRESSIVE FAMILIAL INTRAHEPATIC, 5, Progressive familial intrahepatic cholestasis type 5 |
rs121918299, rs80338722, rs80338725, rs80338719, rs80338723, rs80338726, rs72549401, rs11568372, rs1553469602, rs387907317, rs387906354, rs752919965, rs72549397, rs111033609, rs121909099, rs387906381, rs121909100, rs121909101, rs121909104, rs121909105, rs387906526, rs121918440, rs387906527, rs72552778, rs387906529, rs121918443, rs72552780, rs80338724, rs80338715, rs80338727, rs80338729, rs80338716, rs80338717, rs398122839, rs515726137, rs587777519, rs587777520, rs587777521, rs879255644, rs113090017, rs864321695, rs776869985, rs864321697, rs80338720, rs746155190, rs879255504, rs886041948, rs886042562, rs769910565, rs758069019, rs886043807, rs72549402, rs72549395, rs188824058, rs763782349, rs375315619, rs754287486, rs1057518679, rs1060499649, rs1060499579, rs1554660803, rs1554407511, rs774824767, rs771690686, rs752992432, rs1553466082, rs72549396, rs772294884, rs764513998, rs1202682161, rs759202962, rs1562774655, rs1562831765, rs1562945221, rs917981474, rs1558927163, rs765889649, rs1562976061, rs72549399, rs1459273753, rs377160065, rs1559183717, rs760750012, rs1051861187, rs1558898789, rs928915940, rs752757689, rs1584678508, rs764581483, rs1574453508, rs751511532, rs1182781290, rs376368459, rs762702807, rs1578499691, rs199791850, rs1452792080, rs1458423947, rs1584747270, rs1584750653, rs1599066459, rs1599069873, rs1599166106, rs1574462504, rs1593114820, rs1057524081, rs1588081022, rs777460754, rs1251192873, rs1588117076, rs748671901, rs139314808, rs749009273, rs1588080674, rs1588080680, rs1588127136, rs1588135086, rs757693457, rs1574445178, rs768922690, rs1584422832, rs1584433525, rs1312396424, rs1792048079, rs774411820, rs575729461 View all (111 more) |
21633855, 26888176 |
Liver failure |
Liver Failure |
rs118203990, rs118203991, rs118203992, rs387907022, rs201861847, rs796065037, rs759315662, rs368196005, rs796052121, rs369437593, rs367683258, rs766314948, rs368085185, rs770446752, rs753039116, rs776797592, rs1490906786, rs1562849964, rs759960319, rs776597537, rs375350359, rs1573008071, rs1601977105, rs1174791046, rs1019313682 View all (10 more) |
|
|
Unknown |
Disease term |
Disease name |
Evidence |
References |
Source |
Atherosclerosis |
Atherosclerosis |
|
30996006 |
ClinVar |
Cirrhosis |
Cirrhosis |
|
|
ClinVar |
Crohn disease |
Crohn Disease, Regional enteritis |
|
21829567 |
ClinVar |
Carcinoma |
Carcinoma |
|
|
GWAS |
|
Associations from Text Mining |
Disease Name |
Relationship Type |
References |
Adenocarcinoma |
Stimulate
|
17054793 |
Adenocarcinoma |
Associate
|
27510297 |
Ascites |
Associate
|
31062417 |
Asthma |
Associate
|
31670489 |
Barrett Esophagus |
Stimulate
|
17054793 |
Barrett Esophagus |
Associate
|
27511066 |
Blind Loop Syndrome |
Inhibit
|
23189156 |
Blood Coagulation Disorders |
Associate
|
26888176 |
Breast Neoplasms |
Associate
|
16439808, 17047076, 21499302, 26545738, 32650752 |
Carbamoyl Phosphate Synthase I Deficiency Disease |
Associate
|
31062417 |
Carcinogenesis |
Associate
|
27079614, 30787420, 35449124 |
Carcinogenesis |
Inhibit
|
34995680 |
Carcinoma Hepatocellular |
Associate
|
15604525, 22446874, 23680185, 26165647, 28496032, 28970500, 29958417, 36982249, 37774075 |
Carcinoma Hepatocellular |
Inhibit
|
30787420, 34995680 |
Carcinoma Non Small Cell Lung |
Associate
|
28377627, 35211760 |
Carcinoma Renal Cell |
Associate
|
28496032, 36123627 |
Carcinoma Renal Cell |
Inhibit
|
35931808 |
Carcinoma Squamous Cell |
Associate
|
23341777 |
Carcinoma Squamous Cell |
Inhibit
|
35347542 |
Cerebral Hemorrhage |
Associate
|
38266922 |
Chemical and Drug Induced Liver Injury |
Associate
|
27976737 |
Cholangitis Sclerosing |
Associate
|
28008998 |
Cholestasis |
Associate
|
19187229, 26888176, 28008998, 30778102, 30964181, 32001325 |
Cholestasis |
Inhibit
|
25798860 |
Colitis |
Associate
|
23189156 |
Colitis Ulcerative |
Associate
|
22929053, 35348180 |
Colonic Neoplasms |
Associate
|
24177031, 27079614 |
Colorectal Neoplasms |
Associate
|
24177031, 25596928, 32299194, 34995680, 35348180, 35449124, 36129029 |
Colorectal Neoplasms |
Inhibit
|
36340269 |
COVID 19 |
Associate
|
37697930 |
Crohn Disease |
Inhibit
|
21887309, 23189156 |
Crohn Disease |
Associate
|
32024859, 32678214 |
Diabetes Mellitus |
Associate
|
19059462, 29717168 |
Diabetes Mellitus |
Inhibit
|
35348180 |
Diabetes Mellitus Type 2 |
Associate
|
35046895, 38309826 |
Diabetic Nephropathies |
Associate
|
37337149 |
Dyslipidemias |
Associate
|
29717168 |
End Stage Liver Disease |
Associate
|
26888176, 31062417 |
Enteritis |
Inhibit
|
34995680 |
Enterocolitis Necrotizing |
Associate
|
36371157 |
Esophageal Squamous Cell Carcinoma |
Stimulate
|
33686512 |
Esophagitis |
Stimulate
|
17054793 |
Fatty Liver |
Associate
|
26019035, 36735888 |
Fatty Liver Alcoholic |
Stimulate
|
26019035 |
Fatty Liver Alcoholic |
Associate
|
29717168, 31388096, 31670489 |
Fibrosis |
Inhibit
|
22265968, 27853248 |
Fibrosis |
Associate
|
38266922 |
Fragile X Syndrome |
Associate
|
8668200 |
Gallbladder Neoplasms |
Associate
|
27167107 |
Gallstones |
Associate
|
15810076, 32597704 |
Gastroesophageal Reflux |
Associate
|
33686512 |
Genetic Diseases Inborn |
Associate
|
19228886 |
Graft vs Host Disease |
Associate
|
38429422 |
Heart Failure |
Associate
|
31062417 |
HIV Infections |
Inhibit
|
23106848 |
Hyperbilirubinemia |
Associate
|
27510297 |
Hyperglycemia |
Associate
|
30397356 |
Hypertension Portal |
Associate
|
31062417 |
Hypertriglyceridemia |
Associate
|
12519787 |
Hypoxia |
Inhibit
|
19187229 |
Idiopathic Noncirrhotic Portal Hypertension |
Associate
|
26293907 |
Infant Newborn Diseases |
Associate
|
26888176 |
Inflammation |
Inhibit
|
21887309, 27976737, 34995680 |
Inflammation |
Associate
|
21887309, 22929053, 23189156, 27106679, 27432520, 31062417, 31173497, 33686512, 35348180, 38429422 |
Inflammatory Bowel Diseases |
Inhibit
|
21887309, 32024859 |
Inflammatory Bowel Diseases |
Associate
|
21887309, 22929053, 39490736 |
Intestinal Diseases |
Associate
|
34510400, 39490736 |
Intrahepatic Cholestasis of Pregnancy |
Associate
|
24366234, 24498169, 26888176, 31482549, 35436901 |
Irritable Bowel Syndrome |
Associate
|
24763552 |
Irritable Bowel Syndrome |
Inhibit
|
35348180 |
Ischemia |
Associate
|
19187229 |
Kidney Diseases |
Inhibit
|
27853248 |
Lead Poisoning Nervous System |
Associate
|
36558100 |
Liver Cirrhosis Biliary |
Associate
|
26293907, 30275017 |
Liver Diseases |
Associate
|
19059462, 29717168, 31062417, 31670489, 36558100, 37208429 |
Liver Failure |
Associate
|
19187229 |
Liver Neoplasms |
Associate
|
23680185, 37774075 |
Lymphatic Metastasis |
Stimulate
|
21364590, 23653380 |
Malformations of Cortical Development Group I |
Associate
|
37337149 |
Maturity Onset Diabetes of the Young Type 3 |
Associate
|
23607861 |
Metabolic Diseases |
Associate
|
25725071, 30397356, 31670489 |
Mitochondrial Diseases |
Inhibit
|
22265968 |
Multiple Myeloma |
Associate
|
25669983 |
Mycosis Fungoides |
Associate
|
33299887 |
Neoplasm Metastasis |
Stimulate
|
32650752 |
Neoplasms |
Associate
|
22446874, 27006468, 27079614, 28496032, 31779647, 32299194, 32650752, 33488300, 35347542, 35563650, 36123627, 36340269, 36834607 |
Neoplasms |
Inhibit
|
24177031, 27167107, 28377627, 28970500, 34995680, 35348180 |
Neoplasms |
Stimulate
|
28402278 |
Non alcoholic Fatty Liver Disease |
Associate
|
26019035, 29466845, 30275017, 30778102, 34063472, 36735888 |
Obesity |
Inhibit
|
35348180 |
Osteosarcoma |
Associate
|
31779647 |
Pancreatic Neoplasms |
Associate
|
21364590, 23653380, 28402278 |
Polycystic Ovary Syndrome |
Associate
|
31173497 |
Precancerous Conditions |
Inhibit
|
24177031 |
Proteinuria |
Associate
|
35348180 |
Pulmonary Disease Chronic Obstructive |
Associate
|
36924977 |
Stomach Neoplasms |
Associate
|
23238937, 25095974, 34510400 |
Urinary Bladder Neoplasms |
Associate
|
35563650 |
Uterine Cervical Neoplasms |
Inhibit
|
35347542 |
Uterine Cervical Neoplasms |
Associate
|
35347542 |
Wounds and Injuries |
Associate
|
22265968 |
Xanthomatosis Cerebrotendinous |
Associate
|
15576845 |
|